Afferent loop syndrome is a known complication of pancreaticoduodenectomy. The incidence may be as high as 13%, and survival of 3 years or longer is the only factor associated with its development. [1] Surgical, percutaneous, and endoscopic treatments of afferent loop syndrome have been described, but such treatments are not always feasible. Successful treatment through EUS-guided hepaticogastrostomy has also been reported by our group. [2] We herein present a video case of EUS-guided gastroenterostomy for afferent loop syndrome treatment with SPAXUS® stent (Taewong Medical, Gyeonggi-do, South Korea).
An 80-year-old man, who had undergone Whipple surgery in 2012 for pancreatic adenocarcinoma, was referred for abdominal pain and fever associated with bile duct and afferent loop dilation. A nodule of carcinomatosis localized in the gastrojejunal anastomosis, which was causing the obstruction, was punctured, and carcinoma relapse was histologically confirmed [ Figures 1 and 2 ].
Transgastric puncture of the dilated afferent loop was performed with a 10-Fr Cystotome™ (Cook Medical Ireland, Limrick, Ireland)). Contrast was injected for fluoroscopic viewing of limb and bile duct dilatation [ Figure 3 ]. The incision was enlarged with the 10-Fr Cystotome after insertion of a 0.035-inch guidewire (G-FLEX®, Nivelles, Belgium). A 2-cm-long × 16-mm-diameter ASPAXUS® stent (TaeWoong Medical, Gyeonggi-do, South Korea) was deployed under fluoroscopic view. An 8-mm Hurricane dilatation balloon (Boston Scientific Corp, MA, USA) was then used to dilate the tract within the lumen of the NTI-S™ SPAXUS® stent (Taewong Medical, Gyeonggi-do, South Korea), and a 7-cm × 7-Fr pigtail stent was inserted within the stent to prevent migration [ Figure 4 ].
No serious complication was reported after the procedure, except for abdominal pain, which was managed with analgesic. The patient was discharged 4 days after the procedure. The patient died 3 months after the procedure because of disease progression.
EUS-guided treatment of afferent loop syndrome has been reported using transgastric plastic stent insertion, [3] metallic stent (NAGY and AXIOS), [4, 5] and also hepaticogastrostomy, [2] as we have already mentioned.
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